Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Ebola disease

Accidental exposure to Ebola could be managed with antivirals

New experimental antiviral treatments are a viable option for post-exposure prophylaxis (PEP) against Ebola. In the image, healthcare workers from Guinea undergo training

Source: Lindsey Horton / CDC

Healthcare workers exposed to Ebola virus disease could be managed using a new strategy involving antivirals as post-exposure prophylaxis

For healthcare workers (HCWs) in West Africa, the risk of contracting Ebola virus disease when treating infected patients is not well characterised and there is no consensus on whether to use post-exposure prophylaxis (PEP) after accidental exposure. Now, a UK study published in The Lancet Infectious Diseases[1] has formulated a risk assessment and management strategy.

Eight HCWs who were potentially exposed to the virus were treated according to the strategy. Four HCWs with intermediate or maximum exposure risk received PEP with antiviral agents and follow-up for 42 days. None of the eight HCWs developed Ebola virus disease.

The researchers at the Royal Free London NHS Foundation Trust and Public Health England conclude that new experimental antiviral treatments are a viable option for PEP against Ebola and that standardised risk assessments should be developed to establish their efficacy and safety. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20069254

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • New experimental antiviral treatments are a viable option for post-exposure prophylaxis (PEP) against Ebola. In the image, healthcare workers from Guinea undergo training

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.